On 23 Sep 2014Professor Andre D’Hoore, who chaired both the Guidelines Synthesis report session and the keynote lecture by Evaghelos Xynos, talked with us about rectal prolapse before our annual meeting in Barcelona… “There is a lot of debate on how to manage perianal Crohn’s disease. A recent publication in Gut on a ‘global consensus’ on classification, diagnosis and multidisciplinary treatment demonstrates the shortage of high quality randomised clinical trials for surgical options for patients with Crohn’s disease,” began Professor D’Hoore.
On 22 Sep 2014In the lead up to Barcelona 2014, Dr Marat Khaikin from Chaim Sheba Medical Center, Tel-Hashomer in Israel, who is giving the keynote lecture 'SILS - where are we?', spoke with us about SILS. The potential advantages of moving from multi-port laparoscopic surgery to single incision laparoscopic surgery (SILS) is to reduce the number of ports and thereby: minimise wound related complications, decrease post-operative pain, shorten hospital stay, improve cosmesis, improve cost effectiveness, offer faster recovery; and potentially fewer adhesions so in the long-term it is expected the procedure will result in less complications (such as small bowel obstruction).
On 22 Sep 2014In the lead up to Barcelona 2014, we interviewed Dr Feza H Remzi who presented his keynote lecture 'Timing of Surgery in Crohn’s disease'... In the United States there are approximately one million patients with Crohn’s disease, including those with colitis, according to Dr Remzi, Chairman, Department of Colorectal Surgery, Digestive Disease Institute, Cleveland, OH. Crohn’s disease usually impacts patients aged from their early teens to their late twenties, although it can affect patients of any age.
On 19 Sep 2014We talked to Professor Eric Rullier, who presented the keynote lecture 'Rectal cancer - is it time to do less?' at Barcelona 2014… “There are around 12,000 new cases each year of rectal cancer in France, and along with breast and prostate cancer it is one of the most common cancers, and is successfully treated in approximately 50% of patients, if all patients with and without metastases are considered” said Professor Eric Rullier from the University of Bordeaux in France.
On 18 Sep 2014We talked to Professor Dion Morton, chairing the Clinical Trials Update at Barcelona 2014, who highlights the importance of clinical trials in colorectal surgery… “Historically, medicine was practised on a trial and error basis, by which I mean practitioners would treat patients and would base treatments on what worked and what didn’t work,” began professor Morton. “So the importance of clinical trials is based around the evolution of evidence-based medicine, and the highest qualities of evidence are randomised clinical trials. This is why, for example in the UK, the Department of health has placed randomised clinical trials as the central pillar of high quality medicine.”